Tuesday, February 4, 2025 2/4/2025

Leveraging CDC Opioid Overdose Surveillance Funding from the Albuquerque Area Southwest Tribal Epidemiology Center to Create Tribal Data and Culturally Center Medications for Opioid Use Disorder

Award Number: R61DA049382
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract

Project Summary/Abstract Fatal opioid overdose rates are higher among American Indian/Alaska Native populations than among Hispanics, African Americans, and Asian Americans, and are just below non-Hispanic Whites. AI/AN opioid overdose rates vary significantly by state and county; however, tribe-level differences are difficult to ascertain due to decentralized data systems that divide state health data and Indian Health Service data. While county-level health data is often used as a proxy for tribal data, state data often misclassify AN/AN patients, and in counties containing the lands of multiple tribes, county data may blur significant inter-tribal variation. In addition to limited tribe-specific data, treatment for opioid use disorders also often fails to account for the diversity of tribal populations. On average, patients who take medication for opioid use disorder (MOUD), and specifically methadone or buprenorphine, exhibit improved treatment retention and reduced risk of drug overdose compared to patients not taking MOUD. Some research also shows improved retention for Naltrexone, another MOUD. Because MOUD interventions are rarely tailored to the specific cultural contexts of AI/AN patients, social and cultural barriers to treatment persist in AI/AN communities. To address these problems, we propose to leverage Center for Disease Control funding awarded to the Albuquerque Area Southwest Tribal Epidemiology Center (AASTEC) for improving data quality in opioid overdose surveillance in New Mexico in a two-phase research project. The project will draw upon a community advisory board composed of clinicians and Indian health facility staff, and use a collaboration of epidemiologists from AASTEC and the New Mexico Department of Health, and academic researchers at the University of Utah, University of New Mexico, and Columbia University. In the first phase, we will enhance tribal specificity of AI/AN opioid use disorder and overdose data by linking and geocoding New Mexico vital statistics and syndromic surveillance data. We will then use these data in predictive models to determine the role of modifiable risk and protective factors for specific tribal communities. We will disseminate analysis reports to tribal communities and seek partnerships with tribes and Indian health facilities for the second phase of our research, which entails a community-based participatory research project that will develop and test a culturally centered implementation program for MOUD for use in AI/AN communities. We will use a stepped wedge randomized design in four Indian health facilities to test initiation, retention, relapse, and acceptability of culturally centered MOUD among patients and clinic staff over time. The proposed research will strengthen partnerships between tribal communities, AASTEC, and academic researchers, and better align opioid research with tribal values and priorities. We anticipate our research will not only result in publications in academic journals but will also result in toolkits for creating tribe-specific data estimates for other regions, and protocols for culturally centering MOUD for the contexts of other AI/AN communities and Indian health facilities.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = -$4,245 )
2025	2020	LOYOLA UNIVERSITY OF CHICAGO	2160 S 1ST AVE	MAYWOOD	IL	60153	COOK	USA	Drug Use and Addiction Research Programs	000	3	12/24/2024	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	-$4,245
														Subtotal = -$4,245

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2020	LOYOLA UNIVERSITY OF CHICAGO	2160 S 1ST AVE	MAYWOOD	IL	60153	COOK	USA	Drug Use and Addiction Research Programs	004	3	8/31/2023	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$0
2023	2020	UNIVERSITY OF UTAH	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Drug Use and Addiction Research Programs	002	2	10/22/2022	SUPPLEMENT FOR EXPANSION	-$1
2023	2020	UNIVERSITY OF UTAH	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Drug Use and Addiction Research Programs	001	2	10/22/2022	NON-COMPETING CONTINUATION	-$1
2023	2020	LOYOLA UNIVERSITY OF CHICAGO	2160 S 1ST AVE	MAYWOOD	IL	60153	COOK	USA	Drug Use and Addiction Research Programs	000	3	10/14/2022	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$0
2023	2020	LOYOLA UNIVERSITY OF CHICAGO	2160 S 1ST AVE	MAYWOOD	IL	60153	COOK	USA	Drug Use and Addiction Research Programs	003	3	10/22/2022	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$2
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = -$3,578 )
2022	2020	LOYOLA UNIVERSITY OF CHICAGO	2160 S 1ST AVE	MAYWOOD	IL	60153	COOK	USA	Drug Use and Addiction Research Programs	002	3	5/3/2022	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$548,501
2022	2020	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Drug Use and Addiction Research Programs	003	2	5/4/2022	SUPPLEMENT FOR EXPANSION	-$58,003
2022	2020	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Drug Use and Addiction Research Programs	001	2	5/3/2022	SUPPLEMENT FOR EXPANSION	-$2,561
2022	2020	LOYOLA UNIVERSITY OF CHICAGO	2160 S 1ST AVE	MAYWOOD	IL	60153	COOK	USA	Drug Use and Addiction Research Programs	004	3	5/4/2022	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$58,003
2022	2020	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Drug Use and Addiction Research Programs	000	2	5/3/2022	NON-COMPETING CONTINUATION	-$549,518
														Subtotal = -$3,578

Issue Date FY: 2021 ( Subtotal = $0 )
2021	2020	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Drug Use and Addiction Research Programs	000	2	10/20/2020	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $0

Issue Date FY: 2020 ( Subtotal = $811,735 )
2020	2020	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Drug Use and Addiction Research Programs	000	2	8/5/2020	NON-COMPETING CONTINUATION	$618,673
2020	2020	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Drug Use and Addiction Research Programs	002	2	9/25/2020	SUPPLEMENT FOR EXPANSION	$145,272
2020	2020	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Drug Use and Addiction Research Programs	001	2	8/6/2020	SUPPLEMENT FOR EXPANSION	$47,790
														Subtotal = $811,735

Issue Date FY: 2019 ( Subtotal = $653,895 )
2019	2019	UNIVERSITY OF UTAH, THE	201 S PRESIDENT CIRCLE RM 408	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Drug Use and Addiction Research Programs	000	1	9/3/2019	NEW	$653,895
														Subtotal = $653,895

Grand Total All Awards = $1,457,807

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Leveraging CDC Opioid Overdose Surveillance Funding from the Albuquerque Area Southwest Tribal Epidemiology Center to Create Tribal Data and Culturally Center Medications for Opioid Use Disorder

Award Number: R61DA049382

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer